Literature DB >> 10679664

National Cancer Data Base survey of breast cancer management for patients from low income zip codes.

L S McGinnis1, H R Menck, H J Eyre, K I Bland, C E Scott-Conner, M Morrow, D P Winchester.   

Abstract

BACKGROUND: The National Cancer Data Base (NCDB), a joint project of the American College of Surgeons Commission on Cancer and the American Cancer Society, is a cancer management and outcomes data base for health care organizations. It provides a comparative summary of patient care that is used by participating hospitals and communities for self-assessment. The most current (1995-1996) breast cancer data on patients from low income zip codes are described here.
METHODS: Since 1989, eight Calls for Data have been issued, yielding a total of 191,714 reports of non-Hispanic white patients with breast cancer for the years analyzed, 1995-1996. A total of 1961 hospital cancer registries have participated in at least one of the Calls for Data.
RESULTS: A diverse range of breast cancer cases was reported from a variety of geographic locations and medical care environments. There were general similarities in the treatment of patients from the different income groups; however, some differences were reported. Among patients from lower income zip codes, 60.7% were age 60 years or older, compared with 55.1% from other income zip code groups. The AJCC stage distribution was reported as less favorable for patients from low income zip codes than for other patients. The percentage of patients from low income zip codes diagnosed as Stage 0 or I was 51.2%, compared with 55.9% of patients from the other income zip codes. Of patients from lower income zip codes, 12.1% were reported to have Stage III or IV disease, compared with 10.0% of patients from other income zip codes. Patients from low income zip codes received less tissue-sparing surgery. Of patients from low income zip codes, 14.9% received partial mastectomy with or without radiation or systemic therapy, compared with 18.3% of patients from other income zip codes. The percentage of patients from low income zip codes who received a partial mastectomy with axillary lymph node dissection was 23.3% for patients from other income zip codes, the percentage was 30.5%. Conversely, 49.8% of patients from lower income zip codes received a modified radical mastectomy, compared with 40.5% of patients from other income zip codes.
CONCLUSIONS: Further improvements in the early diagnosis and surgical treatment of low income patients can probably be achieved. Programmatic activities that further explain or reduce the apparent nonpreferred treatment of some low income patients should be encouraged. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Year:  2000        PMID: 10679664

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Breast cancer and women's labor supply.

Authors:  Cathy J Bradley; Heather L Bednarek; David Neumark
Journal:  Health Serv Res       Date:  2002-10       Impact factor: 3.402

2.  Cosmetic outcomes for accelerated partial breast irradiation before surgical excision of early-stage breast cancer using single-dose intraoperative radiotherapy.

Authors:  Randall J Kimple; Nancy Klauber-DeMore; Cherie M Kuzmiak; Dag Pavic; Jun Lian; Chad A Livasy; Laura Esler; Dominic T Moore; Carolyn I Sartor; David W Ollila
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-13       Impact factor: 7.038

3.  Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group.

Authors:  Kathleen M Diehl; Erin M Green; Armin Weinberg; Wayne A Frederick; Dennis R Holmes; Bettye Green; Arden Morris; Henry M Kuerer; Robert A Beltran; Jane Mendez; Venus Gines; David M Ota; Heidi Nelson; Lisa A Newman
Journal:  Ann Surg Oncol       Date:  2011-06-17       Impact factor: 5.344

4.  Considerations of culture and social class for families facing cancer: the need for a new model for health promotion and psychosocial intervention.

Authors:  Catherine A Marshall; Linda K Larkey; Melissa A Curran; Karen L Weihs; Terry A Badger; Julie Armin; Francisco García
Journal:  Fam Syst Health       Date:  2011-06       Impact factor: 1.950

5.  The effect of socioeconomic status on gross total resection, radiation therapy and overall survival in patients with gliomas.

Authors:  Sayantan Deb; Arjun Vivek Pendharkar; Matthew K Schoen; Sean Altekruse; John Ratliff; Atman Desai
Journal:  J Neurooncol       Date:  2017-03-03       Impact factor: 4.130

6.  Local control following single-dose intraoperative radiotherapy prior to surgical excision of early-stage breast cancer.

Authors:  Randall J Kimple; Nancy Klauber-DeMore; Cherie M Kuzmiak; Dag Pavic; Jun Lian; Chad A Livasy; WingKeung M Chiu; Dominic T Moore; Carolyn I Sartor; David W Ollila
Journal:  Ann Surg Oncol       Date:  2011-04       Impact factor: 5.344

7.  Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population.

Authors:  Laura V Bownes; Laura L Stafman; Ilan I Maizlin; Matthew Dellinger; Kenneth W Gow; Adam B Goldin; Melanie Goldfarb; Monica Langer; Mehul V Raval; John J Doski; Jed G Nuchtern; Sanjeev A Vasudevan; Elizabeth A Beierle
Journal:  J Surg Res       Date:  2017-10-06       Impact factor: 2.192

8.  Urban/rural residence moderates effect of race on receipt of surgery in patients with nonmetastatic breast cancer: a report from the South Carolina central cancer registry.

Authors:  N F Esnaola; K Knott; C Finney; M Gebregziabher; M E Ford
Journal:  Ann Surg Oncol       Date:  2008-04-09       Impact factor: 5.344

Review 9.  Socioeconomic status and breast cancer treatment.

Authors:  Marie S Dreyer; Ann B Nattinger; Emily L McGinley; Liliana E Pezzin
Journal:  Breast Cancer Res Treat       Date:  2017-09-07       Impact factor: 4.624

10.  The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.

Authors:  Karl Y Bilimoria; Andrew K Stewart; David P Winchester; Clifford Y Ko
Journal:  Ann Surg Oncol       Date:  2008-01-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.